The prevalence and prognostic significance of KRAS mutation subtypes in lung adenocarcinomas from Chinese populations

by Zheng DF, Wang R, Zhang Y, Pan YJ, Cheng XH, Cheng C, Zheng SB, Li H, Gong RX, Li Y, Shen XX, Sun YH, Chen HQ
Published 2016-02-01

KRT7 Overexpression is Associated with Poor Prognosis and Immune Cell Infiltration in Patients with Pancreatic Adenocarcinoma

by Li Y, Su Z, Wei B, Liang Z
Published 2021-06-01

LncRNA HOTAIRM1 Inhibits the Proliferation and Invasion of Lung Adenocarcinoma Cells via the miR-498/WWOX Axis

by Chen T, Gao F, Yang T, Li H, Li Y, Ren H, Chen M
Published 2020-06-01

Prognostic significance of mucinous component in gastric adenocarcinoma after radical D2 gastrectomy

by Cai L, Li Y, Yang X, Lian X, Guo M, Xiao S, Wang W, Zhang H
Published 2018-02-01

Identification of a transcription factor-microRNA network in esophageal adenocarcinoma through bioinformatics analysis and validation through qRT-PCR

by Chen D, Lu T, Tan J, Zhao K, Li Y, Zhao W, Li H, Wang Q, Wang Y, Wei L
Published 2019-04-01

CD44+ Circulating Tumor Endothelial Cells Indicate Poor Prognosis in Pancreatic Ductal Adenocarcinoma After Radical Surgery: A Pilot Study

by Xing C, Li Y, Ding C, Wang S, Zhang H, Chen L, Li P, Dai M
Published 2021-06-01

Epigallocatechin-3-gallate-induced vascular normalization in A549-cell xenograft-bearing nude mice: therapeutic efficacy in combination with chemotherapy

by Deng P, Hu C, Xiong Z, Li Y, Jiang J, Yang H, Tang Y, Cao L, Lu R
Published 2019-03-01

Lymphovascular Invasion as a Prognostic Factor in Non-Metastatic Adenocarcinoma of Esophagogastric Junction After Radical Surgery

by Zheng C, Feng X, Zheng J, Yan Q, Hu X, Feng H, Deng Z, Liao Q, Wang J, Li Y
Published 2020-12-01

Inhibitors Targeting YAP in Gastric Cancer: Current Status and Future Perspectives

by Yong J, Li Y, Lin S, Wang Z, Xu Y
Published 2021-06-01

PD-L1 in Lung Adenocarcinoma: Insights into the Role of 18F-FDG PET/CT

by Cui Y, Li X, Du B, Diao Y, Li Y
Published 2020-07-01

Prognostic implications of immunohistochemistry markers for EGFR-TKI therapy in Chinese patients with advanced lung adenocarcinoma harboring EGFR mutations

by Zhang R, Li Y, Nie X, Dong X, Wu G
Published 2016-01-01

Impact of Radiotherapy Pattern on the Prognosis of Stage IV Lung Adenocarcinomas Harboring EGFR Mutations

by Zhang Y, Wang W, Xu X, Li Y, Zhang H, Li J, Li Z
Published 2021-04-01